Stephanie A. Freel, Ph.D. - Publications

Affiliations: 
2002 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Molecular Biology, Microbiology Biology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Payne TL, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift NA, Freel SA, Ferrari G, Keene JD, Tomaras GD. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. Journal of Virology. 88: 9514-28. PMID 24899193 DOI: 10.1128/Jvi.00802-14  0.415
2012 Freel SA, Picking RA, Ferrari G, Ding H, Ochsenbauer C, Kappes JC, Kirchherr JL, Soderberg KA, Weinhold KJ, Cunningham CK, Denny TN, Crump JA, Cohen MS, McMichael AJ, Haynes BF, et al. Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication. Journal of Virology. 86: 6835-46. PMID 22514337 DOI: 10.1128/Jvi.00437-12  0.396
2011 Liu P, Overman RG, Yates NL, Alam SM, Vandergrift N, Chen Y, Graw F, Freel SA, Kappes JC, Ochsenbauer C, Montefiori DC, Gao F, Perelson AS, Cohen MS, Haynes BF, et al. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. Journal of Virology. 85: 11196-207. PMID 21865397 DOI: 10.1128/Jvi.05601-11  0.522
2011 Jiang C, Parrish NF, Wilen CB, Li H, Chen Y, Pavlicek JW, Berg A, Lu X, Song H, Tilton JC, Pfaff JM, Henning EA, Decker JM, Moody MA, Drinker MS, ... ... Freel S, et al. Primary infection by a human immunodeficiency virus with atypical coreceptor tropism. Journal of Virology. 85: 10669-81. PMID 21835785 DOI: 10.1128/Jvi.05249-11  0.451
2011 Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S, Moody MA, Alam SM, Tomaras GD, Ochsenbauer C, Kappes JC, Shaw GM, Hoxie JA, Robinson JE, Haynes BF. An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum. Journal of Virology. 85: 7029-36. PMID 21543485 DOI: 10.1128/Jvi.00171-11  0.507
2011 Freel SA, Saunders KO, Tomaras GD. CD8(+)T-cell-mediated control of HIV-1 and SIV infection. Immunologic Research. 49: 135-46. PMID 21170741 DOI: 10.1007/s12026-010-8177-7  0.457
2011 Saunders KO, Ward-Caviness C, Schutte RJ, Freel SA, Overman RG, Thielman NM, Cunningham CK, Kepler TB, Tomaras GD. Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage. Cellular Immunology. 266: 154-64. PMID 21030011 DOI: 10.1016/J.Cellimm.2010.09.011  0.304
2010 Saunders KO, Freel SA, Overman RG, Cunningham CK, Tomaras GD. Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication. Virology. 405: 234-42. PMID 20594570 DOI: 10.1016/j.virol.2010.06.001  0.435
2010 Freel SA, Lamoreaux L, Chattopadhyay PK, Saunders K, Zarkowsky D, Overman RG, Ochsenbauer C, Edmonds TG, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Haynes BF, Koup RA, et al. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. Journal of Virology. 84: 4998-5006. PMID 20200250 DOI: 10.1128/Jvi.00138-10  0.413
2009 Lu RJ, Tucker JA, Pickens J, Ma YA, Zinevitch T, Kirichenko O, Konoplev V, Kuznetsova S, Sviridov S, Brahmachary E, Khasanov A, Mikel C, Yang Y, Liu C, Wang J, ... Freel S, et al. Heterobiaryl human immunodeficiency virus entry inhibitors. Journal of Medicinal Chemistry. 52: 4481-7. PMID 19534463 DOI: 10.1021/Jm900330X  0.436
2009 Saunders KO, Freel SA, Overman R, Cunningham CK, Tomaras GD. P16-40. Inhibition of histone deacetylases modulates CD8+ T-lymphocyte mediated virus suppression by HIV-1 viral controllers Retrovirology. 6: P269. DOI: 10.1186/1742-4690-6-S3-P269  0.432
2003 Freel SA, Fiscus SA, Pilcher CD, Menezes P, Giner J, Patrick E, Lennox JL, Hicks CB, Eron JJ, Shugars DC. Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection. Aids (London, England). 17: 2025-33. PMID 14502005 DOI: 10.1097/00002030-200309260-00003  0.646
2001 Shugars DC, Patton LL, Freel SA, Gray LR, Vollmer RT, Eron JJ, Fiscus SA. Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva. Journal of Dental Research. 80: 414-20. PMID 11332524 DOI: 10.1177/00220345010800020301  0.673
2001 Freel SA, Williams JM, Nelson JA, Patton LL, Fiscus SA, Swanstrom R, Shugars DC. Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. Journal of Virology. 75: 4936-40. PMID 11312368 DOI: 10.1128/Jvi.75.10.4936-4940.2001  0.651
1999 Shugars DC, Alexander AL, Fu K, Freel SA. Endogenous salivary inhibitors of human immunodeficiency virus. Archives of Oral Biology. 44: 445-53. PMID 10401522 DOI: 10.1016/S0003-9969(99)00003-5  0.648
Show low-probability matches.